Headquartered in Smiths Falls, ON Fiscal year ends March NASDAQ: CGC canopygrowth.com
Canopy Growth Corporation is a global cannabis company operating across medical and adult-use cannabis markets in Canada, international markets (primarily Europe), and the vaporizer device market through its Storz & Bickel subsidiary. The company's cannabis portfolio includes owned and licensed brands such as Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL, and R'belle. Canopy Growth is also Canada's largest provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo and Canada House Clinics. The Storz & Bickel business manufactures and sells premium vaporizer devices globally. The company holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market through entities including Wana, Jetty, and Acreage Holdings. Canopy Growth trades on the TSX under WEED and on the Nasdaq under CGC. Updated
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Cannabis investors have watched rescheduling euphoria ignite and incinerate capital at least four times since 2018, and a fresh DEA hearing is now on the calendar. The question is whether this cycle…
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule…
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
Live Updates Insiders are Buying One of the Market’s Worst Performing Stocks1:24pm ETIt’s always a good idea to keep an eye on insider buying. After all, it’s the insiders who know their…
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like…
It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Before U.S. markets open on Thursday, AbbVie, Cameco, Canopy Growth, PepsiCo and Under Armour will report quarterly earnings.
Here is our preview of three companies set to report quarterly earnings before markets open on Wednesday.
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi Technologies, XPO Logistics and Zoominfo Technologies.
Wednesday’s additional top analyst upgrades and downgrades were on Ally Financial, Baker Hughes, Biohaven, Biogen, Bumble, Canopy Growth, Corning, Discover Financial Services, Match, Roku and more.
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.
Marijuana, online betting and storage device companies are on tap to report quarterly results before markets open on Friday.
Canopy Growth Corporation is a global cannabis company operating across medical and adult-use cannabis markets in Canada, international markets (primarily Europe), and the vaporizer device market through its Storz & Bickel subsidiary.
The Wall Street consensus 12-month price target for CGC is $1.20.
